Anew Labs
AI drug discovery combining models with experimental science
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Anew Labs (also referred to as Anew Therapeutics) is an AI pharmaceutical company applying machine learning to drug discovery. Its public platform work spans structure prediction, dynamics-aware sampling, all-atom generative modeling, antibody design, and scientific reasoning models, combined with experimental science and drug-discovery expertise. The company lists offices in Shanghai, San Francisco, and Singapore.
- Website
- anewbt.com
- Stage
- growth
- Location
- Shanghai / San Francisco / Singapore
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Anew Labs AI Drug Discovery Platform — Structure, sampling, design, and reasoning models for drug discovery
- AnewDDE — Agentic drug discovery engine with closed-loop experimental feedback
- Protenix — Open-source biomolecular structure prediction model (AlphaFold 3-class)